Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases (Super-Bio)

Centre Hospitalier Universitaire de Besancon

Status: Completed

Conditions: Inflammation

Treatments: Biological: Blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT02839278

P/2014/233

Details and patient eligibility

About

The aim of the study is to investigate in vitro the impact of a novel anti-inflammatory treatment on costimulatory molecules expressed on monocytes.

Enrollment: 150 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Immune-mediated inflammatory disease (non-ST segment elevation myocardial infarction, Rheumatoid arthritis, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Crohn's disease, Ulcerative colitis, Cystic fibrosis, Psoriasis, Multiple sclerosis or major depressive episode)
• Patient able to understand the reason of the study
• Patient not opposed to the conservation of biological samples for scientific research

Exclusion criteria

• Pregnant woman
• Subject without health insurance

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

150 participants in 1 patient group

Immune-mediated inflammatory disease

Experimental group

Description:

Patients with an immune-mediated inflammatory disease. A blood sample is achieved at T0 (no follow-up).

Treatment:

Biological: Blood sample